#prostate-cancer
Latest news and interesting information about prostate-cancer.
Prostate cancer death risk cut by 20% with J&J drug
Johnson & Johnson's apalutamide reduces prostate cancer death risk by 20%, according to Phase 3 trial results.
J&J prostate cancer drug reduces spread and death risk
J&J's Erleada prostate cancer drug reduces risk of spread and death in late-stage study. New data presented at ASCO.
Novartis radiopharma drug shows promise
Novartis experimental actinium-based radiopharma drug shows anti-tumor activity in prostate cancer, including in patients previously treated with Pluvicto.
Novartis prostate cancer drug shows promise
Novartis experimental actinium-based drug shows promising anti-tumor activity in prostate cancer, significantly reducing PSA levels.
...